Study S000077

Evaluation of a Semaglutide Dose-Tapering Regimen for Weight-Loss Maintenance in Adults With Overweight or Obesity: A Randomized, Non-Inferiority, Open-Label Clinical Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07783854
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 72
Start: 2026-09-01
Primary completion: 2027-12-30
Lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions: Obesity & Overweight
Interventions: DRUG:Semaglutide Dose-Tapering Regimen; DRUG:Semaglutide Maintenance-Dose Regimen
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percentage change in body weight from baseline to week 24 [Baseline (Week 0) to Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.